Angiotensinamide
![]() | |
Systematic (IUPAC) name | |
---|---|
2-[(1-{2-[2-(2-{2-[2-(2-amino-3-carbamoylpropanamido)-5-[(diaminomethylidene)amino]pentanamido]-3-methylbutanamido}-3-(4-hydroxyphenyl)propanamido)-3-methylbutanamido]-3-(1H-imidazol-5-yl)propanoyl}pyrrolidin-2-yl)formamido]-3-phenylpropanoic acid | |
Clinical data | |
Routes of administration | Intravenous infusion |
Identifiers | |
CAS Number |
53-73-6 ![]() |
ATC code | C01CX06 (WHO) |
PubChem | CID 10351092 |
ChemSpider |
8526544 ![]() |
UNII |
7WAL1X78KV ![]() |
KEGG |
D02939 ![]() |
ChEMBL | CHEMBL409803 |
Chemical data | |
Formula | C49H70N14O11 |
Molar mass | 1031.17 g/mol |
| |
| |
(verify) |
Angiotensinamide (INN; BAN and USAN angiotensin amide) is a potent vasoconstrictor used as a cardiac stimulant. It is a derivative of angiotensin II.
See also
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.